Literature DB >> 17062562

Isoform-specific heparan sulfate binding within the amino-terminal noncollagenous domain of collagen alpha1(XI).

Lisa R Warner1, Raquel J Brown, Sorcha M C Yingst, Julia Thom Oxford.   

Abstract

Collagen type XI is a constituent of the pericellular matrix of chondrocytes and plays a role in the regulation of fibrillogenesis. The amino-terminal domain of collagen type XI alpha1 chain is a noncollagenous structure that has been identified on the surface of cartilage collagen fibrils. The biochemical composition of the amino-terminal domain varies due to alternative splicing of the primary transcript. Recombinantly expressed alpha1(XI) aminoterminal domain isoforms were used in this study to investigate potential interactions. Purified products were analyzed for heparan sulfate binding properties. The results demonstrated that two additional binding sites exist within the alpha1(XI) aminoterminal domain, one within the amino propeptide and one within the variable region of the amino-terminal domain. Analysis of relative affinities indicated that the site located within the amino propeptide (site 1) was of similar affinity to sites that exist within the major triple helix of collagen type XI. Substitution of amino acid residues 147 to 152 within the amino propeptide by site-directed mutagenesis resulted in altered affinity for heparan sulfate. The binding site located within the variable region (site 2) demonstrated significantly higher affinity than other sites within the molecule. Displacement of collagen type XI within the pericellular matrix was observed in cell culture in the presence of excess heparan sulfate and by treatment with heparinase. These studies suggest two additional binding sites located within the noncollagenous amino-terminal domain that may play a role in the function of collagen type XI. The localization of collagen type XI within the pericellular matrix may be dependent upon interactions with heparan sulfate proteoglycans, and these are likely to take place in an isoform-specific manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062562      PMCID: PMC2948787          DOI: 10.1074/jbc.M608551200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Structural model of the amino propeptide of collagen XI alpha1 chain with similarity to the LNS domains.

Authors:  Arzhang Fallahi; Becky Kroll; Lisa R Warner; Rex J Oxford; Katey M Irwin; Linda M Mercer; Susan E Shadle; Julia Thom Oxford
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

2.  Temporal and spatial expression of alternative splice-forms of the alpha1(XI) collagen gene in fetal rat cartilage.

Authors:  G B Davies; J T Oxford; L C Hausafus; B F Smoody; N P Morris
Journal:  Dev Dyn       Date:  1998-09       Impact factor: 3.780

Review 3.  Structure and distribution of modules in extracellular proteins.

Authors:  P Bork; A K Downing; B Kieffer; I D Campbell
Journal:  Q Rev Biophys       Date:  1996-05       Impact factor: 5.318

4.  Alternative mRNA processing occurs in the variable region of the pro-alpha 1(XI) and pro-alpha 2(XI) collagen chains.

Authors:  N I Zhidkova; S K Justice; R Mayne
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

5.  Alternative exon splicing within the amino-terminal nontriple-helical domain of the rat pro-alpha 1(XI) collagen chain generates multiple forms of the mRNA transcript which exhibit tissue-dependent variation.

Authors:  J T Oxford; K J Doege; N P Morris
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

6.  Expression of cell-surface proteoglycan mRNA by human articular chondrocytes.

Authors:  J Grover; P J Roughley
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

7.  Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain.

Authors:  Guido Veit; Birgit Kobbe; Douglas R Keene; Mats Paulsson; Manuel Koch; Raimund Wagener
Journal:  J Biol Chem       Date:  2005-12-05       Impact factor: 5.157

8.  Pro-alpha3(V) collagen chain is expressed in bone and its basic N-terminal peptide adheres to osteosarcoma cells.

Authors:  Kenji Yamaguchi; Noritaka Matsuo; Hideaki Sumiyoshi; Noritaka Fujimoto; Ken-Ich Iyama; Shigetaka Yanagisawa; Hidekatsu Yoshioka
Journal:  Matrix Biol       Date:  2005-06       Impact factor: 11.583

9.  Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1).

Authors:  H Yoshioka; K Iyama; K Inoguchi; M Khaleduzzaman; Y Ninomiya; F Ramirez
Journal:  Dev Dyn       Date:  1995-09       Impact factor: 3.780

10.  Ultrastructural localization of collagen types II, IX, and XI in the growth plate of human rib and fetal bovine epiphyseal cartilage: type XI collagen is restricted to thin fibrils.

Authors:  D R Keene; J T Oxford; N P Morris
Journal:  J Histochem Cytochem       Date:  1995-10       Impact factor: 2.479

View more
  13 in total

1.  Disruption of the developmentally-regulated Col2a1 pre-mRNA alternative splicing switch in a transgenic knock-in mouse model.

Authors:  Renate Lewis; Soumya Ravindran; Louisa Wirthlin; Geoffrey Traeger; Russell J Fernandes; Audrey McAlinden
Journal:  Matrix Biol       Date:  2012-01-09       Impact factor: 11.583

2.  The expression patterns of minor fibrillar collagens during development in zebrafish.

Authors:  Ming Fang; Jason S Adams; B Lane McMahan; Raquel J Brown; Julia Thom Oxford
Journal:  Gene Expr Patterns       Date:  2010-07-18       Impact factor: 1.224

3.  Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.

Authors:  Randall E Ryan; Bryan Martin; Liliana Mellor; Reed B Jacob; Ken Tawara; Owen M McDougal; Julia Thom Oxford; Cheryl L Jorcyk
Journal:  Cytokine       Date:  2015-01-23       Impact factor: 3.861

4.  Proteomic analysis of Col11a1-associated protein complexes.

Authors:  Raquel J Brown; Christopher Mallory; Owen M McDougal; Julia Thom Oxford
Journal:  Proteomics       Date:  2011-11-23       Impact factor: 3.984

Review 5.  Minor fibrillar collagens, variable regions alternative splicing, intrinsic disorder, and tyrosine sulfation.

Authors:  Ming Fang; Reed Jacob; Owen McDougal; Julia Thom Oxford
Journal:  Protein Cell       Date:  2012-07-01       Impact factor: 14.870

6.  Characterization of collagenous matrix assembly in a chondrocyte model system.

Authors:  Sorcha Yingst; Kaci Bloxham; Lisa R Warner; Raquel J Brown; Jennifer Cole; Linda Kenoyer; William B Knowlton; Julia Thom Oxford
Journal:  J Biomed Mater Res A       Date:  2009-07       Impact factor: 4.396

7.  Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.

Authors:  John Gallagher
Journal:  Int J Exp Pathol       Date:  2015-07-15       Impact factor: 1.925

8.  Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens.

Authors:  Makrina Karaglani; Ioannis Toumpoulis; Nikolaos Goutas; Nikoleta Poumpouridou; Dimitrios Vlachodimitropoulos; Spyridon Vasilaros; Ioannis Rizos; Christos Kroupis
Journal:  BMC Cancer       Date:  2015-10-14       Impact factor: 4.430

9.  Alternative splicing modifies the effect of mutations in COL11A1 and results in recessive type 2 Stickler syndrome with profound hearing loss.

Authors:  Allan J Richards; Gregory S Fincham; Annie McNinch; David Hill; Arabella V Poulson; Bruce Castle; Melissa M Lees; Anthony T Moore; John D Scott; Martin P Snead
Journal:  J Med Genet       Date:  2013-08-06       Impact factor: 6.318

10.  Splice-altering variant in COL11A1 as a cause of nonsyndromic hearing loss DFNA37.

Authors:  Kevin T Booth; James W Askew; Zohreh Talebizadeh; Patrick L M Huygen; James Eudy; Judith Kenyon; Denise Hoover; Michael S Hildebrand; Katherine R Smith; Melanie Bahlo; William J Kimberling; Richard J H Smith; Hela Azaiez; Shelley D Smith
Journal:  Genet Med       Date:  2018-09-24       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.